Skip to main content
Erschienen in: Obesity Surgery 4/2011

01.04.2011 | Clinical Report

Evaluation of Bone Mineral Density Loss in Morbidly Obese Women After Gastric Bypass: 3-Year Follow-Up

verfasst von: Nuria Vilarrasa, Patricia San José, Isabel García, Carmen Gómez-Vaquero, Pilar Medina Miras, Amador G. Ruiz de Gordejuela, Carles Masdevall, Jordi Pujol, Joan Soler, José Manuel Gómez

Erschienen in: Obesity Surgery | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Studies that evaluate the influence of gastric bypass (RYGP) on bone mass are limited to short-term follow-up. We analysed changes in bone mineral density (BMD) three years after surgery and evaluated the main determinants of the development of bone disease. Prospective study of 59 morbidly obese white women aged 46 ± 8 years. BMD scanning using DEXA and plasma determinations of calcium, parathyroid hormone, 25-hydroxyvitamin D and insulin-like growth factor-I were made prior, at 12 months and 3 years after surgery. In the first postoperative year BMD decreased at femoral neck (FN) 10.2 % and in the lumbar spine (LS) 3.2 %, in the third year it additionally decreased 2.7 % and 3.1 %, respectively. BMD at both sites remained above the values of women of the same age. In the follow-up, 1.7 % developed osteoporosis at FN and 6.8 % at LS. Patients with bone disease were older, the percentage of women with menopause was greater in this group and had lower initial and final values of lean mass. The percentage of BMD loss at FN remained positively associated with the percentage of lean mass loss [β 0.304, p = 0.045], and menopause [β 0.337, p = 0.025]. Major osteoporotic fracture and hip fracture risk was low even in menopausal patients (3.1 % and 0.40 %, respectively). After RYGP menopausal women and those with greater lean mass loss are at higher risk of BMD loss but progression to osteoporosis is uncommon and the risk of fracture is low.
Literatur
1.
Zurück zum Zitat De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330–8.CrossRefPubMed De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330–8.CrossRefPubMed
2.
Zurück zum Zitat Ensurd KE, Lipschutz RC, Cauley JA, et al. Body size and hip fracture risk in older women—a prospective study. Am J Med. 1997;103:274–80.CrossRef Ensurd KE, Lipschutz RC, Cauley JA, et al. Body size and hip fracture risk in older women—a prospective study. Am J Med. 1997;103:274–80.CrossRef
3.
Zurück zum Zitat Revilla M, Villa LF, Sanchez-Atrio A, et al. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int. 1997;61:134–8.CrossRefPubMed Revilla M, Villa LF, Sanchez-Atrio A, et al. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int. 1997;61:134–8.CrossRefPubMed
4.
Zurück zum Zitat Ricci TA, Heymsfield SB, Pierson RN, et al. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr. 2001;73:347–52.PubMed Ricci TA, Heymsfield SB, Pierson RN, et al. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr. 2001;73:347–52.PubMed
5.
Zurück zum Zitat Lean JM, Jagger CJ, Chambers TJ, et al. Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol. 1995;268:E318–22.PubMed Lean JM, Jagger CJ, Chambers TJ, et al. Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol. 1995;268:E318–22.PubMed
6.
Zurück zum Zitat Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int. 1996;59:492–5.PubMed Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcif Tissue Int. 1996;59:492–5.PubMed
7.
Zurück zum Zitat Cornish J, Callon KE, Cooper GJS, et al. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun. 1995;207:133–9.CrossRefPubMed Cornish J, Callon KE, Cooper GJS, et al. Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun. 1995;207:133–9.CrossRefPubMed
8.
Zurück zum Zitat Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002;175:405–15.CrossRefPubMed Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002;175:405–15.CrossRefPubMed
9.
Zurück zum Zitat Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. The bone-adipose axis in obesity and weight loss. Obes Surg. 2008;18:1134–43.CrossRefPubMed Gómez-Ambrosi J, Rodríguez A, Catalán V, et al. The bone-adipose axis in obesity and weight loss. Obes Surg. 2008;18:1134–43.CrossRefPubMed
10.
Zurück zum Zitat Gómez JM, Vilarrasa N, Masdevall C, et al. Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg. 2009;19:345–50.CrossRefPubMed Gómez JM, Vilarrasa N, Masdevall C, et al. Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg. 2009;19:345–50.CrossRefPubMed
11.
Zurück zum Zitat Vilarrasa N, Gómez JM, Masdevall C, et al. Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass. Endocrinol nutr. 2009;56:355–60.CrossRefPubMed Vilarrasa N, Gómez JM, Masdevall C, et al. Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass. Endocrinol nutr. 2009;56:355–60.CrossRefPubMed
12.
Zurück zum Zitat Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turn-over and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89:1061–5.CrossRefPubMed Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turn-over and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89:1061–5.CrossRefPubMed
13.
Zurück zum Zitat Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density following gastric bypass surgery is associated with extend of weight loss. J Clin Endocrinol Metab. 2008;93:3735–40.CrossRefPubMed Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density following gastric bypass surgery is associated with extend of weight loss. J Clin Endocrinol Metab. 2008;93:3735–40.CrossRefPubMed
14.
Zurück zum Zitat Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009;19:41–6.CrossRefPubMed Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009;19:41–6.CrossRefPubMed
15.
Zurück zum Zitat Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone and vitamin D. J Gastrointest Surg. 2005;9:1106–10.CrossRefPubMed Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone and vitamin D. J Gastrointest Surg. 2005;9:1106–10.CrossRefPubMed
16.
Zurück zum Zitat Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7.CrossRefPubMed Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7.CrossRefPubMed
17.
Zurück zum Zitat Valderas JP, Velasco S, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y Gastric bypass. Obes Surg. 2009;19:1132–8.CrossRefPubMed Valderas JP, Velasco S, Solari S, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y Gastric bypass. Obes Surg. 2009;19:1132–8.CrossRefPubMed
18.
Zurück zum Zitat Mahdy T, Atia S, Farid M, et al. Effect of Roux-en-Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18:1526–31.CrossRefPubMed Mahdy T, Atia S, Farid M, et al. Effect of Roux-en-Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18:1526–31.CrossRefPubMed
19.
Zurück zum Zitat Vilarrasa N, Gomez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg. 2009;19:860–6.CrossRefPubMed Vilarrasa N, Gomez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg. 2009;19:860–6.CrossRefPubMed
20.
Zurück zum Zitat De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57–61.CrossRefPubMed De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57–61.CrossRefPubMed
21.
Zurück zum Zitat Hamoui N, Kim K, Anthone G, et al. The significance of elevated levels of parathyroid hormone in patient with morbid obesity before and after surgery. Arch Surg. 2003;138:891–7.CrossRefPubMed Hamoui N, Kim K, Anthone G, et al. The significance of elevated levels of parathyroid hormone in patient with morbid obesity before and after surgery. Arch Surg. 2003;138:891–7.CrossRefPubMed
22.
Zurück zum Zitat Goldner WS, O’Dorisio TM, Dillon JS, et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685–92.CrossRefPubMed Goldner WS, O’Dorisio TM, Dillon JS, et al. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685–92.CrossRefPubMed
23.
Zurück zum Zitat Slater GH, Ren CF, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55.CrossRefPubMed Slater GH, Ren CF, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55.CrossRefPubMed
24.
Zurück zum Zitat Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at 6 and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010;95:159–66.CrossRefPubMed Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at 6 and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010;95:159–66.CrossRefPubMed
25.
Zurück zum Zitat Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone. 2009;44:734–43.CrossRefPubMed Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone. 2009;44:734–43.CrossRefPubMed
26.
Zurück zum Zitat Kanis JA, Mc Closkey E, Johansson H, et al. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21 suppl 2:S 407–13. Kanis JA, Mc Closkey E, Johansson H, et al. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21 suppl 2:S 407–13.
27.
Zurück zum Zitat Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.CrossRefPubMed Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.CrossRefPubMed
28.
Zurück zum Zitat World Health Organization. Obesity: preventing and managing the global epidemic. In: Report on a WHO consultation on obesity. WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 3–5 June, 1997. World Health Organization. Obesity: preventing and managing the global epidemic. In: Report on a WHO consultation on obesity. WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 3–5 June, 1997.
29.
Zurück zum Zitat Alonso GC, Curiel MD, Carranza FH, et al. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000;11:714–20.CrossRefPubMed Alonso GC, Curiel MD, Carranza FH, et al. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000;11:714–20.CrossRefPubMed
30.
Zurück zum Zitat Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.CrossRefPubMed Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.CrossRefPubMed
31.
Zurück zum Zitat Villareal DT, Citivelli R, Chines A, et al. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab. 1991;72:628–34.CrossRefPubMed Villareal DT, Citivelli R, Chines A, et al. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab. 1991;72:628–34.CrossRefPubMed
32.
Zurück zum Zitat Thomas MK, Lloyd-Jones DM, Thadhani RI. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–83.CrossRefPubMed Thomas MK, Lloyd-Jones DM, Thadhani RI. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–83.CrossRefPubMed
33.
Zurück zum Zitat Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24:675–80.CrossRefPubMed Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24:675–80.CrossRefPubMed
34.
Zurück zum Zitat Gjesdal CG, Halse JL, Eide GE, et al. Impact of lean mass and fat mass on bone mineral density: The Hordaland Health study. Maturitas. 2008;59:191–200.CrossRefPubMed Gjesdal CG, Halse JL, Eide GE, et al. Impact of lean mass and fat mass on bone mineral density: The Hordaland Health study. Maturitas. 2008;59:191–200.CrossRefPubMed
35.
Zurück zum Zitat Rendina D, Gianfrancesco F, De Filippo G, et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol. 2010;163:165–72.CrossRefPubMed Rendina D, Gianfrancesco F, De Filippo G, et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol. 2010;163:165–72.CrossRefPubMed
36.
Zurück zum Zitat El-Kadre LJ, Rocha PR, de Almeida Tinoco AC. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1062–6.CrossRefPubMed El-Kadre LJ, Rocha PR, de Almeida Tinoco AC. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1062–6.CrossRefPubMed
37.
Zurück zum Zitat Diniz MF, Diniz MT, Sanches SR, et al. Elevated serum paratohormone after Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1222–6.CrossRefPubMed Diniz MF, Diniz MT, Sanches SR, et al. Elevated serum paratohormone after Roux-en-Y gastric by-pass. Obes Surg. 2004;14:1222–6.CrossRefPubMed
38.
Zurück zum Zitat Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393–6.CrossRefPubMed Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007;21:1393–6.CrossRefPubMed
39.
Zurück zum Zitat Zofkova I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res. 2003;52:657–79.PubMed Zofkova I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res. 2003;52:657–79.PubMed
40.
Zurück zum Zitat Collins D, Woods A, Herd R, et al. Insulin-like growth factor-I and bone mineral density. Bone. 1998;23:13–6.CrossRefPubMed Collins D, Woods A, Herd R, et al. Insulin-like growth factor-I and bone mineral density. Bone. 1998;23:13–6.CrossRefPubMed
41.
Zurück zum Zitat Van Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 1998;67:734–8.PubMed Van Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 1998;67:734–8.PubMed
42.
Zurück zum Zitat Tothill P, Hannan WJ, Cowen S, et al. Anomalies in the measurement of changes in total-body bone mineral by dual-energy X-ray absorptiometry during weight change. J Bone Miner Res. 1997;12:1908–21.CrossRefPubMed Tothill P, Hannan WJ, Cowen S, et al. Anomalies in the measurement of changes in total-body bone mineral by dual-energy X-ray absorptiometry during weight change. J Bone Miner Res. 1997;12:1908–21.CrossRefPubMed
Metadaten
Titel
Evaluation of Bone Mineral Density Loss in Morbidly Obese Women After Gastric Bypass: 3-Year Follow-Up
verfasst von
Nuria Vilarrasa
Patricia San José
Isabel García
Carmen Gómez-Vaquero
Pilar Medina Miras
Amador G. Ruiz de Gordejuela
Carles Masdevall
Jordi Pujol
Joan Soler
José Manuel Gómez
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 4/2011
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0338-1

Weitere Artikel der Ausgabe 4/2011

Obesity Surgery 4/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.